(Q36662835)

15 August 2017

Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI. (English)

1 reference

enzyme replacement therapy

15 August 2017

0 references

7

Ans T van der Ploeg

1 reference

15 August 2017

3

Marloes L C Hagemans

1 reference

15 August 2017

1

Marion M M G Brands

1 reference

15 August 2017

Ingrid M Frohn-Mulder

2

1 reference

15 August 2017

Wim C J Hop

4

1 reference

15 August 2017

Esmee Oussoren

5

1 reference

15 August 2017

Wim A Helbing

6

1 reference

15 August 2017

26 January 2012

1 reference

Journal of Inherited Metabolic Disease

15 August 2017

1 reference

15 August 2017

36

1 reference

15 August 2017

2

1 reference

15 August 2017

227-234

1 reference

Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Mucopolysaccharidosis VI: the Italian experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Heart valve macro- and microstructure

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

The frequency of lysosomal storage diseases in The Netherlands.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Echocardiographic abnormalities in type IV mucopolysaccharidosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Echocardiographic abnormalities in the mucopolysaccharide storage diseases.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Endocardial fibroelastosis in mucopolysaccharidosis type VI.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Cardiovascular studies in the mucopolysaccharidoses

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590414

Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children.

28 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9444-Z

Enzyme-replacement therapy in mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9444-Z

Echocardiographic study of paediatric patients with mucopolysaccharidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9444-Z

Left ventricular mass in 169 healthy children and young adults assessed by three-dimensional echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9444-Z

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9444-Z

Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9444-Z

The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses

21 January 2018

1 reference

12 December 2020

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype

1 reference

12 December 2020

Cardiovascular changes in children with mucopolysaccharide disorders

1 reference

12 December 2020

Cardiac structural involvement in mucopolysaccharidoses

1 reference

12 December 2020

Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--clinical and echocardiographic findings in 64 patients

1 reference

12 December 2020

Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

12 December 2020

Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I

1 reference

12 December 2020

10.1007/S10545-011-9444-Z

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

22278137

1 reference